Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) | Zendy

Robert P. Myers | Zendy; Curtis Cooper | Zendy; Morris Sherman | Zendy; Richard Lalonde | Zendy; Helga Witt-Sullivan | Zendy; Magdy Elkashab | Zendy; Paul Harris | Zendy; Robert Balshaw | Zendy; Christopher Usaty | Zendy; Paul J. Marotta | Zendy

Open Access

Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)

Author(s) -

Robert P. Myers,

Curtis Cooper,

Morris Sherman,

Richard Lalonde,

Helga Witt-Sullivan,

Magdy Elkashab,

Paul Harris,

Robert Balshaw,

Christopher Usaty,

Paul J. Marotta

Publication year - 2011

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2011/698780

Subject(s) - ribavirin , medicine , discontinuation , hepatitis c virus , hepatitis c , chronic hepatitis , quality of life (healthcare) , observational study , mental health , gastroenterology , immunology , virus , psychiatry , nursing

In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research